Eli Lilly (LLY) EBT (2009 - 2026)

Eli Lilly (LLY) has reported EBT for 18 consecutive years, with $8.9 billion the latest figure, recorded in Q1 2026.

• EBT for Q1 2026 came in at $8.9 billion, up 156.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.1 billion (up 128.86% YoY), and the FY2025 annual result was $25.7 billion, up 102.93% from the prior year.
• EBT was $8.9 billion for Q1 2026 at Eli Lilly, up from $8.3 billion in the prior quarter.
• Over five years, EBT peaked at $8.9 billion in Q1 2026 and troughed at $427.2 million in Q3 2023.
• Average EBT over 5 years is $3.6 billion, with a median of $2.5 billion recorded in 2023.
• Year-over-year, EBT slumped 72.71% in 2023 and surged 355.33% in 2025.
• Over 5 years, EBT stood at $2.1 billion in 2022, then climbed by 19.64% to $2.5 billion in 2023, then surged by 100.87% to $5.0 billion in 2024, then surged by 64.07% to $8.3 billion in 2025, then gained by 7.06% to $8.9 billion in 2026.
• Per Business Quant data, the three most recent EBT figures were $8.9 billion in Q1 2026, $8.3 billion in Q4 2025, and $7.2 billion in Q3 2025.